Prescient Therapeutics Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Prescient Therapeutics.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 16.2% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
We Think Prescient Therapeutics (ASX:PTX) Can Afford To Drive Business Growth
Mar 12
We're Not Very Worried About Prescient Therapeutics' (ASX:PTX) Cash Burn Rate
Nov 14Companies Like Prescient Therapeutics (ASX:PTX) Are In A Position To Invest In Growth
Aug 01Shareholders Would Not Be Objecting To Prescient Therapeutics Limited's (ASX:PTX) CEO Compensation And Here's Why
Nov 22Here's Why We're Not Too Worried About Prescient Therapeutics' (ASX:PTX) Cash Burn Situation
Oct 19Prescient Therapeutics (ASX:PTX) Is In A Strong Position To Grow Its Business
Jun 19Prescient Therapeutics (ASX:PTX) Is In A Strong Position To Grow Its Business
Feb 27We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Prescient Therapeutics Limited's (ASX:PTX) CEO For Now
Nov 05We Think Prescient Therapeutics (ASX:PTX) Can Easily Afford To Drive Business Growth
Aug 26Prescient Therapeutics (ASX:PTX) Is In A Good Position To Deliver On Growth Plans
May 08Does Prescient Therapeutics' (ASX:PTX) CEO Salary Compare Well With The Performance Of The Company?
Jan 11
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Prescient Therapeutics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | 3 | -8 | -8 | -8 | N/A |
| 9/30/2023 | 3 | -7 | -7 | -7 | N/A |
| 6/30/2023 | 2 | -7 | -6 | -6 | N/A |
| 3/31/2023 | 2 | -6 | -6 | -6 | N/A |
| 12/31/2022 | 2 | -5 | -5 | -5 | N/A |
| 9/30/2022 | 2 | -5 | -5 | -5 | N/A |
| 6/30/2022 | 2 | -5 | -4 | -4 | N/A |
| 3/31/2022 | 2 | -5 | -4 | -4 | N/A |
| 12/31/2021 | 1 | -5 | -4 | -4 | N/A |
| 9/30/2021 | 1 | -5 | -4 | -4 | N/A |
| 6/30/2021 | 1 | -4 | -4 | -4 | N/A |
| 3/31/2021 | 1 | -4 | -4 | -4 | N/A |
| 12/31/2020 | 1 | -3 | -3 | -3 | N/A |
| 9/30/2020 | 1 | -3 | -3 | -3 | N/A |
| 6/30/2020 | 1 | -3 | -2 | -2 | N/A |
| 3/31/2020 | 1 | -4 | -2 | -2 | N/A |
| 12/31/2019 | 2 | -4 | -2 | -2 | N/A |
| 9/30/2019 | 2 | -4 | -3 | -3 | N/A |
| 6/30/2019 | 2 | -4 | -4 | -4 | N/A |
| 3/31/2019 | 1 | -3 | -3 | -3 | N/A |
| 12/31/2018 | 1 | -3 | -3 | -3 | N/A |
| 9/30/2018 | 1 | -3 | -2 | -2 | N/A |
| 6/30/2018 | 1 | -3 | -2 | -2 | N/A |
| 3/31/2018 | 1 | -3 | -3 | -3 | N/A |
| 12/31/2017 | 1 | -3 | -3 | -3 | N/A |
| 9/30/2017 | 1 | -3 | N/A | -3 | N/A |
| 6/30/2017 | 1 | -3 | N/A | -3 | N/A |
| 3/31/2017 | 1 | -2 | N/A | -3 | N/A |
| 12/31/2016 | 1 | -2 | N/A | -2 | N/A |
| 9/30/2016 | 1 | -2 | N/A | -2 | N/A |
| 6/30/2016 | 1 | -2 | N/A | -2 | N/A |
| 3/31/2016 | 1 | -2 | N/A | -2 | N/A |
| 12/31/2015 | 1 | -2 | N/A | -2 | N/A |
| 9/30/2015 | 1 | -2 | N/A | -2 | N/A |
| 6/30/2015 | 0 | -2 | N/A | -2 | N/A |
| 3/31/2015 | 0 | -2 | N/A | N/A | N/A |
| 12/31/2014 | 0 | -2 | N/A | -1 | N/A |
| 9/30/2014 | 0 | -2 | N/A | -1 | N/A |
| 6/30/2014 | 0 | -2 | N/A | -1 | N/A |
| 3/31/2014 | 0 | -1 | N/A | N/A | N/A |
| 12/31/2013 | 0 | -1 | N/A | -1 | N/A |
| 9/30/2013 | 0 | 0 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if PTX's forecast earnings growth is above the savings rate (2.2%).
Earnings vs Market: Insufficient data to determine if PTX's earnings are forecast to grow faster than the Australian market
High Growth Earnings: Insufficient data to determine if PTX's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if PTX's revenue is forecast to grow faster than the Australian market.
High Growth Revenue: Insufficient data to determine if PTX's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PTX's Return on Equity is forecast to be high in 3 years time